134 related articles for article (PubMed ID: 15082419)
1. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats.
Ran J; Hirano T; Adachi M
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E227-32. PubMed ID: 15082419
[TBL] [Abstract][Full Text] [Related]
2. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
[TBL] [Abstract][Full Text] [Related]
3. Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats.
Okada K; Hirano T; Ran J; Adachi M
Hypertens Res; 2004 Apr; 27(4):293-9. PubMed ID: 15127887
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
Kusumoto K; Igata H; Ojima M; Tsuboi A; Imanishi M; Yamaguchi F; Sakamoto H; Kuroita T; Kawaguchi N; Nishigaki N; Nagaya H
Eur J Pharmacol; 2011 Nov; 669(1-3):84-93. PubMed ID: 21816148
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis.
Yokozawa J; Sasaki T; Ohwada K; Sasaki Y; Ito JI; Saito T; Kawata S
J Gastroenterol; 2009; 44(6):583-91. PubMed ID: 19365601
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes.
Mizuno M; Sada T; Kato M; Koike H
Hypertens Res; 2002 Mar; 25(2):271-8. PubMed ID: 12047043
[TBL] [Abstract][Full Text] [Related]
7. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
[TBL] [Abstract][Full Text] [Related]
8. Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats.
Ran J; Hirano T; Adachi M
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E955-61. PubMed ID: 15213064
[TBL] [Abstract][Full Text] [Related]
9. Vitamin A status affects obesity development and hepatic expression of key genes for fuel metabolism in Zucker fatty rats.
Zhang Y; Li R; Li Y; Chen W; Zhao S; Chen G
Biochem Cell Biol; 2012 Aug; 90(4):548-57. PubMed ID: 22554462
[TBL] [Abstract][Full Text] [Related]
10. Olmesartan ameliorates peripheral nerve dysfunction in Zucker diabetic fatty rats.
Sugimoto K; Kojima K; Baba M; Yasujima M
J Hypertens; 2011 Jul; 29(7):1337-46. PubMed ID: 21602711
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats.
Ran J; Hirano T; Adachi M
J Hypertens; 2005 Aug; 23(8):1525-30. PubMed ID: 16003179
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
[TBL] [Abstract][Full Text] [Related]
13. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
Igarashi M; Hirata A; Nozaki H; Kadomoto-Antsuki Y; Tominaga M
Diabetes Res Clin Pract; 2007 Mar; 75(3):267-77. PubMed ID: 16934905
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
[TBL] [Abstract][Full Text] [Related]
15. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats.
Muñoz MC; Giani JF; Dominici FP; Turyn D; Toblli JE
J Hypertens; 2009 Dec; 27(12):2409-20. PubMed ID: 19901849
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor antagonists prevent glucose-induced increases in islet blood flow in rats.
Iwase M; Uchizono Y; Nohara S; Sasaki N; Sonoki K; Iida M
Scand J Clin Lab Invest; 2009; 69(1):145-50. PubMed ID: 18937099
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
Rizzoni D; Pasini E; Flati V; Rodella LF; Paiardi S; Assanelli D; De Ciuceis C; Porteri E; Boari GE; Rezzani R; Speca S; Favero G; Martinotti S; Toniato E; Platto C; Agabiti-Rosei E
J Hypertens; 2008 Aug; 26(8):1595-601. PubMed ID: 18622238
[TBL] [Abstract][Full Text] [Related]
19. A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
Izuhara Y; Sada T; Yanagisawa H; Koike H; Ohtomo S; Dan T; Ito S; Nangaku M; van Ypersele de Strihou C; Miyata T
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1767-73. PubMed ID: 18658044
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
